Related references
Note: Only part of the references are listed.Tau neuropathology correlates with FDG-PET, but not AV-1451-PET, in progressive supranuclear palsy
Ruben Smith et al.
ACTA NEUROPATHOLOGICA (2017)
Small vessel disease burden in cerebral amyloid angiopathy without symptomatic hemorrhage
Gregoire Boulouis et al.
NEUROLOGY (2017)
Cerebral Microvascular Accumulation of Tau Oligomers in Alzheimer's Disease and Related Tauopathies
Diana L. Castillo-Carranza et al.
AGING AND DISEASE (2017)
Enhanced Tau Aggregation in the Presence of Amyloid β
Rachel E. Bennett et al.
AMERICAN JOURNAL OF PATHOLOGY (2017)
Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits
Gorka Gerenu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease
Rosemary J. Jackson et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Matrix metalloproteinases in the brain and blood-brain barrier: Versatile breakers and makers
Ralf G. Rempe et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2016)
Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia
Taya Thomas et al.
BRAIN (2015)
IV and IP Administration of Rhodamine in Visualization of WBC-BBB Interactions in Cerebral Vessels
Zachary Wilmer Reichenbach et al.
MICROSCOPY RESEARCH AND TECHNIQUE (2015)
Do glia drive synaptic and cognitive impairment in disease?
Won-Suk Chung et al.
NATURE NEUROSCIENCE (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Clinical and imaging features of mixed Alzheimer and vascular pathologies
Helena C. Chui et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Transcriptomics Profiling of Alzheimer's Disease Reveal Neurovascular Defects, Altered Amyloid-beta Homeostasis, and Deregulated Expression of Long Noncoding RNAs
Marco Magistri et al.
JOURNAL OF ALZHEIMERS DISEASE (2015)
The overlap between vascular disease and Alzheimer's disease - lessons from pathology
Johannes Attems et al.
BMC MEDICINE (2014)
Plasminogen activator inhibitor-1 as an early potential diagnostic marker for Alzheimer's disease
Jaeho Oh et al.
EXPERIMENTAL GERONTOLOGY (2014)
Plasminogen activator inhibitor type 1 regulates microglial motility and phagocytic activity
Hyejin Jeon et al.
JOURNAL OF NEUROINFLAMMATION (2012)
Morphological and Pathological Evolution of the Brain Microcirculation in Aging and Alzheimer's Disease
Jesse M. Hunter et al.
PLOS ONE (2012)
VEGF-initiated angiogenesis and the uPA/uPAR system
Johannes M. Breuss et al.
CELL ADHESION & MIGRATION (2012)
Transcranial Doppler ultrasound blood flow velocity and pulsatility index as systemic indicators for Alzheimer's disease
Alex E. Roher et al.
ALZHEIMERS & DEMENTIA (2011)
Multiplexed Immunoassay Panel Identifies Novel CSF Biomarkers for Alzheimer's Disease Diagnosis and Prognosis
Rebecca Craig-Schapiro et al.
PLOS ONE (2011)
Amyloid Triggers Extensive Cerebral Angiogenesis Causing Blood Brain Barrier Permeability and Hypervascularity in Alzheimer's Disease
Kaan E. Biron et al.
PLOS ONE (2011)
Lowering Midlife Levels of Systolic Blood Pressure as a Public Health Strategy to Reduce Late-Life Dementia Perspective From the Honolulu Heart Program/Honolulu Asia Aging Study
Lenore J. Launer et al.
HYPERTENSION (2010)
A Review of String Vessels or Collapsed, Empty Basement Membrane Tubes
William R. Brown
JOURNAL OF ALZHEIMERS DISEASE (2010)
Arterial Spin Labeling Blood Flow MRI: Its Role in the Early Characterization of Alzheimer's Disease
David C. Alsop et al.
JOURNAL OF ALZHEIMERS DISEASE (2010)
Tau Mislocalization to Dendritic Spines Mediates Synaptic Dysfunction Independently of Neurodegeneration
Brian R. Hoover et al.
NEURON (2010)
Evidence of angiogenic vessels in Alzheimer's disease
Brinda S. Desai et al.
JOURNAL OF NEURAL TRANSMISSION (2009)
Functional reactivity of cerebral capillaries
Bojana Stefanovic et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Monica Garcia-Alloza et al.
NEUROBIOLOGY OF DISEASE (2006)
VEGF gene and phenotype relation with Alzheimer's disease and mild cognitive impairment
Martina Chiappelli et al.
REJUVENATION RESEARCH (2006)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Mutant presenilins specifically elevate the levels of the 42 residue β-amyloid peptide in vivo:: evidence for augmentation of a 42-specific γ secretase
JL Jankowsky et al.
HUMAN MOLECULAR GENETICS (2004)
Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology
MA Pappolla et al.
NEUROLOGY (2003)
Cerebral perfusion SPET correlated with Braak pathological stage in Alzheimer's disease
K. M. Bradley et al.
BRAIN (2002)
Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia
E Tarkowski et al.
NEUROBIOLOGY OF AGING (2002)
Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils
J Götz et al.
SCIENCE (2001)
The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin:: Implications for antiangiogenic strategies
K Bajou et al.
JOURNAL OF CELL BIOLOGY (2001)
Immunohistochemical localization of plasminogen activator inhibitor-1 in rat and human brain tissues
H Hino et al.
NEUROSCIENCE LETTERS (2001)
Share Paper
